#Study

Eric Meyerowitz, MD

EricMeyerowitz

1/ Thoughts on the exciting world of tocilizumab for treatment of COVID-19.RECOVERY tocilizumab preprint posted earlier today is another landmark paper and an enormous contribution to our expanding COVID-19 treatment

Sarah Mulhern Gross

thereadingzone

Every piece of media seems focused on this news from the CDC, but I wonder how many people have gone beyond the headline/Facebook post and read the early release? Let’s

Constantino Xavier

ConstantinoX

How to build a public policy research career in India? What to do, what to avoid?Yesterday we welcomed a new group of awesome interns to Brookings India.I shared a few

Dr. Theresa Chapple

Theresa_Chapple

My thoughts on the study from Wisconsin schools- a "COVID-19 Cases and Transmission in 17 K–12 Schools — Wood County, Wisconsin, August 31–November 29, 2020 | MMWR"https://www.cdc.gov/mmwr/volumes/70/wr/mm7004e3.htm?s_cid=mm

Samuel Marsh, Ph.D.

samuel_marsh

New year seems like as good a time as any for another reminder: Be careful with your animal models! This edition brought to you by the Cre/Lox system. #methodsmatter 1/n

The Upcoming Artist Guide

Thejollofdiary

The Matthew Effect extends across all fronts, even in Music.A social phenomenon that depicts how advantage begets further advantage. Primarily, it is linked to “the rich gets richer and poor

Sarah Huskisson

ScienceIsWild

1. As zoo-based cognitive research programs become more common, @LydiaMHopper, @chimpfreq, and I wanted to test if animals’ task accuracy is influenced by visitors watching them, suggestive of attentional bias

TulsaTeresa

TulsaTeresa

COVID-19 has taken an outsize toll on Black and Hispanic Americans. And those disparities extend to the medical workers who have intubated them, cleaned their bedsheets and held their hands

Elea McDonnell Feit

eleafeit

Do advertisers care about where their display ads appear?Some answers from a recent study by @silalom, @nnabout, and @eleafeit. Full paper at https://arxiv.org/abs/2012.00840 . When a major private RTB ad exchange

The Pathfinder

path1finder

Thread about $XENE Xenon Pharmceuticals‘ main asset XEN1101: XEN1101 is a – presumably – much improved version of an older approved drug: ezogabine (= retigabine; trade names EU/USA Trobalt/Potiga). This

Joe Cavallo MD, MBA

JCavallo972

There is a rather dishonest Igraham segment circulating online about masks. So I thought I would take a look at it. This type of misinformation is actively harmful. Here is

Emilia C Skirmuntt 🦇🧬🦠

ESkirmuntt

It is very irresponsible for news agencies to post articles about vaccines and pandemic research before this research is published. It happens all the time since this pandemic started and

Cambridge Law

cambtweetlaw

After seeing this tweet, I wanted to make sure that potential applicants have the information they need so that they know what financial support is really on offer to them.

Sam Wineburg

samwineburg

1/9 Lateral reading, what's it all about? A bunch of people have asked for resources. A lot of stuff has been scattered across the Web. So here it is in

Sara "cisn't" Springer

saraaspringer

CW for dysphoria and transphobia. But if you work in OCD/ED/BDD research, please pay attention to this one. I'll elaborate a bit.https://www.lgbtqnation.com/2021/02/medical-school-suspends-study-tortured-transgender-people-science/ I

Stephanie M. Lee

stephaniemlee

Just had a lovely week offline. Now I am here, reading an (unlabeled) op-ed in @sciam, from the same two authors who made the same argument in @undarkmag in June.I

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.